Helen Louise Collins - Jul 28, 2021 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Marc Grasso, Attorney-in-fact for Helen Collins
Stock symbol
KURA
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
4
Date filed
7/29/2021, 05:17 PM
Next filing
Jun 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +46K $0.00 46K Jul 28, 2021 Common Stock 46K $18.98 Direct F1
transaction KURA Option to purchase common stock Award $0 +19.2K $0.00 19.2K Jul 28, 2021 Common Stock 19.2K $18.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
F2 This option vests in full on the one year anniversary of the date of grant.